| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 67,676 | 50,185 | 46,989 | 60,787 | | Cost of Revenue | 51,079 | 38,568 | 38,215 | 47,530 | | | Gross Profit | 16,597 | 11,617 | 8,774 | 13,257 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 14,100 | 11,982 | 11,612 | 14,014 | | Non Recurring |
-
| 460 | 957 | 13,250 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,497 | (825) | (3,795) | (14,007) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3 | (4) | 18 | 45 | | Earnings Before Interest And Taxes | 2,500 | (829) | (3,777) | (13,962) | | Interest Expense | 37 | (10) | 12 | 44 | | Income Before Tax | 2,463 | (819) | (3,789) | (14,006) | | Income Tax Expense | 826 | (562) | (1,322) | (629) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,637 | (257) | (2,467) | (13,377) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,637 | (257) | (2,467) | (13,377) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,637 | ($257) | ($2,467) | ($13,377) |
|
0.31% Nasdaq 
0.05%
Income Statement
